| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/06/2023 | -0.96% | DA Davidson | $11.5 → $17 | Maintains | Neutral |
| 02/03/2023 | -30.09% | Morgan Stanley | $10 → $12 | Maintains | Underweight |
| 12/15/2022 | -12.61% | Piper Sandler | → $15 | Initiates Coverage On | → Overweight |
| 11/14/2022 | -33% | DA Davidson | $14.5 → $11.5 | Maintains | Neutral |
| 08/12/2022 | -0.96% | Cowen & Co. | → $17 | Downgrades | Outperform → Market Perform |
| 08/08/2022 | -15.53% | DA Davidson | $16 → $14.5 | Maintains | Neutral |
| 08/08/2022 | -35.92% | Morgan Stanley | $12 → $11 | Maintains | Underweight |
| 06/29/2022 | — | Raymond James | Downgrades | Market Perform → Underperform | |
| 06/16/2022 | -30.09% | Morgan Stanley | $19 → $12 | Downgrades | Equal-Weight → Underweight |
| 05/13/2022 | -6.79% | DA Davidson | $19.5 → $16 | Maintains | Neutral |
| 05/05/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 11/15/2021 | 33.99% | Morgan Stanley | $22 → $23 | Maintains | Equal-Weight |
| 11/04/2021 | 28.17% | Oppenheimer | $24 → $22 | Maintains | Outperform |
| 08/02/2021 | 28.17% | Morgan Stanley | $23 → $22 | Maintains | Equal-Weight |
| 07/30/2021 | 28.17% | DA Davidson | $26 → $22 | Maintains | Neutral |
| 07/14/2021 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 06/22/2021 | 74.77% | Cowen & Co. | → $30 | Upgrades | Market Perform → Outperform |
| 06/22/2021 | 39.82% | Oppenheimer | → $24 | Upgrades | Perform → Outperform |
| 05/07/2021 | 33.99% | Morgan Stanley | $14 → $23 | Maintains | Equal-Weight |
| 03/11/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 02/05/2021 | -18.44% | Morgan Stanley | $13 → $14 | Maintains | Equal-Weight |
| 01/20/2021 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 11/16/2020 | -35.92% | B of A Securities | $12 → $11 | Maintains | Underperform |
| 11/13/2020 | -35.92% | DA Davidson | $12.5 → $11 | Maintains | Neutral |
| 11/03/2020 | -6.79% | Oppenheimer | $19 → $16 | Maintains | Outperform |
| 06/04/2020 | 10.69% | Oppenheimer | → $19 | Upgrades | Perform → Outperform |
| 05/07/2020 | -35.92% | Baird | $10 → $11 | Maintains | Neutral |
| 05/07/2020 | -47.57% | Morgan Stanley | $7 → $9 | Maintains | Underweight |
| 04/21/2020 | -41.74% | Baird | $17 → $10 | Maintains | Neutral |
| 03/17/2020 | -41.74% | Morgan Stanley | $14 → $10 | Maintains | Underweight |
| 03/16/2020 | -30.09% | Wells Fargo | $16 → $12 | Maintains | Equal-Weight |
| 01/21/2020 | — | DA Davidson | Upgrades | Underperform → Neutral | |
| 11/14/2019 | -27.18% | DA Davidson | $15 → $12.5 | Downgrades | Neutral → Underperform |
| 07/12/2019 | -30.09% | Jefferies | $14 → $12 | Upgrades | Underperform → Hold |
| 06/24/2019 | -18.44% | DA Davidson | $16.5 → $14 | Maintains | Neutral |
| 12/20/2018 | — | Citigroup | Initiates Coverage On | → Underweight | |
| 10/24/2018 | -21.35% | Jefferies | → $13.5 | Downgrades | Hold → Underperform |
| 10/04/2018 | -6.79% | B of A Securities | $14 → $16 | Maintains | Underperform |
| 08/07/2018 | -18.44% | BMO Capital | $16 → $14 | Maintains | Market Perform |
| 08/06/2018 | -24.26% | Morgan Stanley | $13.5 → $13 | Maintains | Underweight |
| 07/16/2018 | — | B of A Securities | Downgrades | Neutral → Underperform | |
| 06/20/2018 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 05/04/2018 | -0.96% | B of A Securities | $19 → $17 | Maintains | Neutral |
| 05/04/2018 | -21.35% | Morgan Stanley | $15.5 → $13.5 | Maintains | Underweight |
| 05/04/2018 | -6.79% | BMO Capital | $18 → $16 | Maintains | Market Perform |
| 05/04/2018 | — | Baird | Downgrades | Outperform → Neutral | |
| 03/26/2018 | -6.79% | DA Davidson | $17 → $16 | Maintains | Neutral |
| 02/09/2018 | 4.86% | BMO Capital | $16 → $18 | Maintains | Market Perform |
What is the target price for Sally Beauty Holdings (SBH)?
The latest price target for Sally Beauty Holdings (NYSE: SBH) was reported by DA Davidson on February 6, 2023. The analyst firm set a price target for $17.00 expecting SBH to fall to within 12 months (a possible -0.96% downside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sally Beauty Holdings (SBH)?
The latest analyst rating for Sally Beauty Holdings (NYSE: SBH) was provided by DA Davidson, and Sally Beauty Holdings maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Sally Beauty Holdings (SBH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sally Beauty Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sally Beauty Holdings was filed on February 6, 2023 so you should expect the next rating to be made available sometime around February 6, 2024.
Is the Analyst Rating Sally Beauty Holdings (SBH) correct?
While ratings are subjective and will change, the latest Sally Beauty Holdings (SBH) rating was a maintained with a price target of $11.50 to $17.00. The current price Sally Beauty Holdings (SBH) is trading at is $17.17, which is out of the analyst's predicted range.